Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valérie Dutoit

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|March 3, 2020
Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma PatientsValérie Dutoit, Géraldine Philippin, Valérie Widmer, et al.
Biomedicines|December 23, 2023
c-Met<sup>+</sup> Cytotoxic T Lymphocytes Exhibit Enhanced Cytotoxicity in Mice and Humans In Vitro Tumor ModelsMahdia Benkhoucha, Ngoc Lan Tran, Isis Senoner, et al.
Oncoimmunology|September 14, 2020
Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade gliomaEliana Marinari, Mathilde Allard, Robin Gustave, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1Frédérique-Anne Le Gal, Maha Ayyoub, Valérie Dutoit, et al.
Oncoimmunology|September 19, 2017
First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapiesDenis Migliorini, Nicolas Mach, Diego Aguiar, et al.
Molecular Therapy. Oncology|November 19, 2024
A novel mitochondrial pyruvate carrier inhibitor drives stem cell-like memory CAR T cell generation and enhances antitumor efficacyMathias Wenes, Anouk Lepez, Vladimir Arinkin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTLVerena Rubio-Godoy, Valérie Dutoit, Yingdong Zhao, et al.
Cancer Immunity|October 29, 2003
Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccineDanila Valmori, Valérie Dutoit, Maha Ayyoub, et al.
Molecular Therapy. Methods & Clinical Development|March 17, 2025
Magnetic bead-sensitized optoporation coupled with antibodies-based activation for mRNA CAR-T cell manufacturingNoelia Maldonado-Pérez, Marie-Agnès Doucey, Dzhangar Dzhumashev, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCRValérie Dutoit, Verena Rubio-Godoy, Marie-Agnès Doucey, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|March 3, 2020
Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma PatientsValérie Dutoit, Géraldine Philippin, Valérie Widmer, et al.
Biomedicines|December 23, 2023
c-Met<sup>+</sup> Cytotoxic T Lymphocytes Exhibit Enhanced Cytotoxicity in Mice and Humans In Vitro Tumor ModelsMahdia Benkhoucha, Ngoc Lan Tran, Isis Senoner, et al.
Oncoimmunology|September 14, 2020
Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade gliomaEliana Marinari, Mathilde Allard, Robin Gustave, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1Frédérique-Anne Le Gal, Maha Ayyoub, Valérie Dutoit, et al.
Oncoimmunology|September 19, 2017
First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapiesDenis Migliorini, Nicolas Mach, Diego Aguiar, et al.
Molecular Therapy. Oncology|November 19, 2024
A novel mitochondrial pyruvate carrier inhibitor drives stem cell-like memory CAR T cell generation and enhances antitumor efficacyMathias Wenes, Anouk Lepez, Vladimir Arinkin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTLVerena Rubio-Godoy, Valérie Dutoit, Yingdong Zhao, et al.
Cancer Immunity|October 29, 2003
Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccineDanila Valmori, Valérie Dutoit, Maha Ayyoub, et al.
Molecular Therapy. Methods & Clinical Development|March 17, 2025
Magnetic bead-sensitized optoporation coupled with antibodies-based activation for mRNA CAR-T cell manufacturingNoelia Maldonado-Pérez, Marie-Agnès Doucey, Dzhangar Dzhumashev, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCRValérie Dutoit, Verena Rubio-Godoy, Marie-Agnès Doucey, et al.
Pageof 7